Results 211 to 220 of about 68,267 (269)
Some of the next articles are maybe not open access.
Emergency Medicine Clinics of North America, 1993
Hemophilia and von Willebrand's disease are the most common hereditary bleeding disorders. A variety of treatment modalities of these disorders are discussed. Common organ system bleeding and its treatment and disposition are outlined. Finally, potential complications of both the disease and treatment are reviewed.
J A, Pfaff, M, Geninatti
openaire +2 more sources
Hemophilia and von Willebrand's disease are the most common hereditary bleeding disorders. A variety of treatment modalities of these disorders are discussed. Common organ system bleeding and its treatment and disposition are outlined. Finally, potential complications of both the disease and treatment are reviewed.
J A, Pfaff, M, Geninatti
openaire +2 more sources
Thrombosis and Haemostasis, 1961
SummaryHemophilia A is reported in a Shetland sheepdog. The history, clotting defects and clinical course were similar to that seen in human hemophilia. As far as we know, no evidence of hemophilia has been reported in this breed. Bleeding episodes could be controlled by fresh frozen plasma given either intravenously or intraperitoneally.Due to the ...
H A, WURZEL, W C, LAWRENCE
openaire +2 more sources
SummaryHemophilia A is reported in a Shetland sheepdog. The history, clotting defects and clinical course were similar to that seen in human hemophilia. As far as we know, no evidence of hemophilia has been reported in this breed. Bleeding episodes could be controlled by fresh frozen plasma given either intravenously or intraperitoneally.Due to the ...
H A, WURZEL, W C, LAWRENCE
openaire +2 more sources
Thrombosis and Haemostasis, 1964
SummaryA new canine hemophilia kindred is reported.
P, DIDISHEIM, D L, BUNTING
openaire +2 more sources
SummaryA new canine hemophilia kindred is reported.
P, DIDISHEIM, D L, BUNTING
openaire +2 more sources
Pediatric Clinics of North America, 1980
The clinical manifestations of hemophilia depend upon both age and the severity of the factor VIII or IX deficiency. Hemophilia A and B cannot be differentiated on clinical grounds. Laboratory tests include platelet count, prothrombin time, partial thromboplastin time, and bleeding time.
openaire +2 more sources
The clinical manifestations of hemophilia depend upon both age and the severity of the factor VIII or IX deficiency. Hemophilia A and B cannot be differentiated on clinical grounds. Laboratory tests include platelet count, prothrombin time, partial thromboplastin time, and bleeding time.
openaire +2 more sources
American Journal of Clinical Pathology, 1982
An acquired circulating inhibitor to Factor VIII:C was found in a 27-year-old postpartum woman who presented with ecchymoses and hematomas. Postpartum Factor VIII:C inhibitors can clinically manifest with signs and symptoms not unlike those in a classic hemophiliac.
B S, Shitamoto +2 more
openaire +2 more sources
An acquired circulating inhibitor to Factor VIII:C was found in a 27-year-old postpartum woman who presented with ecchymoses and hematomas. Postpartum Factor VIII:C inhibitors can clinically manifest with signs and symptoms not unlike those in a classic hemophiliac.
B S, Shitamoto +2 more
openaire +2 more sources
Hematology/Oncology Clinics of North America, 1992
Over the past few years considerable progress has been made in elucidating the molecular genetics of hemophilia A, in carrier detection and prenatal diagnosis, and in the production of safer clotting factor concentrates. Recombinant FVIII, shown to be safe and effective in ongoing prelicensure clinical trials that began in the spring of 1987, should ...
J M, Lusher, I, Warrier
openaire +2 more sources
Over the past few years considerable progress has been made in elucidating the molecular genetics of hemophilia A, in carrier detection and prenatal diagnosis, and in the production of safer clotting factor concentrates. Recombinant FVIII, shown to be safe and effective in ongoing prelicensure clinical trials that began in the spring of 1987, should ...
J M, Lusher, I, Warrier
openaire +2 more sources
American Pharmacy, 1994
Hemophilias A and B are inherited disorders of clotting-factor production that are characterized by low levels of factor VIII- or IX-coagulant activity. The clinical course of patients with hemophilia is marked by episodes of hemorrhage, some spontaneous and some related to trauma or medical procedures.
openaire +2 more sources
Hemophilias A and B are inherited disorders of clotting-factor production that are characterized by low levels of factor VIII- or IX-coagulant activity. The clinical course of patients with hemophilia is marked by episodes of hemorrhage, some spontaneous and some related to trauma or medical procedures.
openaire +2 more sources
New England Journal of Medicine, 2001
J D, Punch, R M, Merion, J G, Turcotte
openaire +3 more sources
J D, Punch, R M, Merion, J G, Turcotte
openaire +3 more sources